Kim H - Search Results

1

Diabetic Mesenchymal Stem Cells Are Ineffective for Improving Limb Ischemia Due to Their Impaired Angiogenic Capability.

Kim H, Han JW, Lee JY, Choi YJ, Sohn YD, Song M, Yoon YS. Kim H, et al. Cell Transplant. 2015;24(8):1571-84. doi: 10.3727/096368914X682792. Epub 2014 Jul 8. Cell Transplant. 2015. PMID: 25008576 Free PMC article.

2

Angiopoietin-2 stimulates blood flow recovery after femoral artery occlusion by inducing inflammation and arteriogenesis.

Tressel SL, Kim H, Ni CW, Chang K, Velasquez-Castano JC, Taylor WR, Yoon YS, Jo H. Tressel SL, et al. Among authors: kim h. Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):1989-95. doi: 10.1161/ATVBAHA.108.175463. Epub 2008 Sep 4. Arterioscler Thromb Vasc Biol. 2008. PMID: 18772493 Free PMC article.

3

Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy.

Jeong JO, Kim MO, Kim H, Lee MY, Kim SW, Ii M, Lee JU, Lee J, Choi YJ, Cho HJ, Lee N, Silver M, Wecker A, Kim DW, Yoon YS. Jeong JO, et al. Among authors: kim h, kim mo, kim dw, kim sw. Circulation. 2009 Feb 10;119(5):699-708. doi: 10.1161/CIRCULATIONAHA.108.789297. Epub 2009 Jan 26. Circulation. 2009. PMID: 19171856 Free PMC article.

4

Cell therapy with bone marrow cells for myocardial regeneration.

Kim H, Kim SW, Nam D, Kim S, Yoon YS. Kim H, et al. Among authors: kim sw, kim s. Antioxid Redox Signal. 2009 Aug;11(8):1897-911. doi: 10.1089/ars.2009.2486. Antioxid Redox Signal. 2009. PMID: 19203213 Free PMC article. Review.

5

Bone marrow mononuclear cells have neurovascular tropism and improve diabetic neuropathy.

Kim H, Park JS, Choi YJ, Kim MO, Huh YH, Kim SW, Han JW, Lee J, Kim S, Houge MA, Ii M, Yoon YS. Kim H, et al. Among authors: kim mo, kim sw, kim s. Stem Cells. 2009 Jul;27(7):1686-96. doi: 10.1002/stem.87. Stem Cells. 2009. PMID: 19544451 Free PMC article.

6

CD31+ cells represent highly angiogenic and vasculogenic cells in bone marrow: novel role of nonendothelial CD31+ cells in neovascularization and their therapeutic effects on ischemic vascular disease.

Kim H, Cho HJ, Kim SW, Liu B, Choi YJ, Lee J, Sohn YD, Lee MY, Houge MA, Yoon YS. Kim H, et al. Among authors: kim sw. Circ Res. 2010 Sep 3;107(5):602-14. doi: 10.1161/CIRCRESAHA.110.218396. Epub 2010 Jul 15. Circ Res. 2010. PMID: 20634489 Free PMC article.

7

Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease.

Kim SW, Kim H, Cho HJ, Lee JU, Levit R, Yoon YS. Kim SW, et al. Among authors: kim h. J Am Coll Cardiol. 2010 Aug 10;56(7):593-607. doi: 10.1016/j.jacc.2010.01.070. J Am Coll Cardiol. 2010. PMID: 20688215 Free PMC article.

8

Podoplanin-expressing cells derived from bone marrow play a crucial role in postnatal lymphatic neovascularization.

Lee JY, Park C, Cho YP, Lee E, Kim H, Kim P, Yun SH, Yoon YS. Lee JY, et al. Among authors: kim h, kim p. Circulation. 2010 Oct 5;122(14):1413-25. doi: 10.1161/CIRCULATIONAHA.110.941468. Epub 2010 Sep 20. Circulation. 2010. PMID: 20855662 Free PMC article.

9

Advances in bone marrow-derived cell therapy: CD31-expressing cells as next generation cardiovascular cell therapy.

Kim SW, Kim H, Yoon YS. Kim SW, et al. Among authors: kim h. Regen Med. 2011 May;6(3):335-49. doi: 10.2217/rme.11.24. Regen Med. 2011. PMID: 21548739 Free PMC article.

10

Emerging therapy for diabetic neuropathy: cell therapy targeting vessels and nerves.

Kim H, Kim JJ, Yoon YS. Kim H, et al. Among authors: kim jj. Endocr Metab Immune Disord Drug Targets. 2012 Jun;12(2):168-78. doi: 10.2174/187153012800493486. Endocr Metab Immune Disord Drug Targets. 2012. PMID: 22236028 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97,056 results

Search Page